News
Novartis opens new frontier in Voyager gene therapy alliance
Novartis has doubled down on its gene therapy collaboration with …
19756 items found
News
Novo Nordisk will open AI hub in London
Novo Nordisk is planning to open an artificial intelligence (AI) …
News
Verona cuts $400m loan deal as it preps COPD drug for market
Verona Pharma has agreed a new $400 million debt facility with Oxford …
News
AZ, Sanofi’s Beyfortus cleared in China for RSV prevention
AstraZeneca and Sanofi’s long-acting antibody Beyfortus has been …
News
Astellas strikes $1.7bn SIRP drug deal with Elpiscience
Astellas has struck a deal with fellow Japanese pharma company …
News
Lawsuit claims J&J illegally delayed Stelara biosimilars
A lawsuit in the US is accusing Johnson & Johnson of unlawfully …
News
Roche bolsters diagnostics with $295m LumiraDx deal
A flurry of mergers and acquisitions in the pharma space at the end …
Market Access
The race to develop innovative products and supply chain solutions
In the final instalment of the five-part, festive series of the …
Patients
Calculus’s Liz Klein: Investing in a changing landscape
In the ever-evolving realm of healthcare and pharmaceuticals, the …
News
Eisai working on wristband sensor for brain amyloid
Eisai has joined forces with Oita University in Japan to develop a …
R&D
The smart-design evolution of the laboratory space
In this penultimate instalment of the five-part, festive series of …
Patients
Navigating transplant networks: Ensuring equitable access and improving outcomes for highly sensitised kidney transplant patients
Over three million people live with kidney disease in the UK. Some …
News
AZ confirms its China president is under investigation
The head of AstraZeneca's Chinese operations has been placed under investigation by the authorities in Beijing, although the reasons for the probe remain unclear.
Sales & Marketing
Enabling site success: Key insights to reducing burden and i...
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Digital
A journey from personal to public: Digital health passports ...
A digital health passport is an app, or online certification, that displays a traveller’s health or vaccination record. It can save lives, on both private and public levels.
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
Less than three weeks away: Join Global Experts at Transderm...
11-12 November 2024 in London, UK
R&D
Partner Content
4th mRNA Analytical Development & Quality Control Summit | F...
Excitement for mRNA therapeutics continues, as RNA technologies are awarded the Nobel Prize for the second year running.
